SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Frida Kahlo — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFrida Kahlo
Date of birth1907-07-06
IdentifiersMRN HR-NI011-SYN-TD; SSN (made up) 000-11-4390
Document date1944-10-01
AuthorMarisol Ortega, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week chronic pain follow-up on the day of the rehabilitation consultation. [S]

History of Present Illness

Ms. Kahlo returns two weeks after her first visit, on the day of her physical medicine and rehabilitation consultation. The rehabilitation plan starts physical therapy twice a week with graded exercise, core and hip strengthening, and aquatic therapy, with a shoe lift for her shorter right leg; her first session is today. She has taken duloxetine 30 mg daily for two weeks. It caused mild nausea for the first few days, which has passed, and no dizziness, sweating, or sleep change. She takes acetaminophen 1 g three times a day and uses the diclofenac gel on her ankle, which makes standing easier. She still takes no more than four oxycodone tablets a day and has needed no early refills. The burning in her right leg is a little less at night. She can stand at the easel for about 15 minutes before the pain makes her sit. She has agreed to a first small reduction in her oxycodone dose at the four-week visit, provided her function holds, and asks that the taper stay slow. [S]

ElementDetail
RehabilitationConsultation today; physical therapy twice weekly starts today; shoe lift prescribed
Duloxetine 30 mgTwo weeks; brief early nausea, now gone
Opioid useNo more than four oxycodone tablets a day; no early refills
FunctionStands at the easel for about 15 minutes
TaperAgrees to a first small reduction at the four-week visit
PEG7.0, from 7.3 at intake

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo drowsiness, fever, or weight change
GastrointestinalNegativeNausea gone; no constipation; bowel habit unchanged
MusculoskeletalPositiveConstant low back and pelvic pain; right ankle pain on standing; no falls
NeurologicalPositiveBurning in the right leg, a little less at night; no new weakness or numbness; no bladder or bowel control change
PsychiatricPositiveFrustrated at times by pain; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Oxycodone 10 mg oral tablet, one tablet every 6 hours as needed for pain, no more than four a day (60 MME a day)One tablet by mouth every 6 hours as needed for pain; no more than 4 tablets a dayOral route1942-03-04 to 1944-10-15completedS
Duloxetine 30 mg delayed-release oral capsule, one capsule dailyOne capsule by mouth dailyOral route1944-09-17 to 1944-10-01completedS
Duloxetine 60 mg delayed-release oral capsule, one capsule dailyOne capsule by mouth dailyOral route1944-10-01activeS
Acetaminophen 500 mg oral tablet, two tablets three times dailyTwo tablets by mouth three times daily; no more than 3,000 mg a dayOral route1944-09-17activeS
Diclofenac sodium 1% topical gel, 2 g to the right ankle four times dailyApply 2 g to the right ankle and foot four times dailyTopical route1944-09-17activeS
Cholecalciferol (vitamin D3) 2,000 units oral tablet, one tablet dailyOne tablet by mouth dailyOral route1944-09-17activeS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose; may repeat in the other nostrilFor suspected opioid overdose: one spray into one nostril and call 911; if there is no response after 2 to 3 minutes, give a second spray in the other nostrilNasal route1944-09-17activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1944-10-01Body height160cmS
1944-10-01Body weight50kgS
1944-10-01Body mass index (BMI) [Ratio]19.5kg/m2S
1944-10-01Systolic blood pressure116mm[Hg]S
1944-10-01Diastolic blood pressure72mm[Hg]S
1944-10-01Heart rate80/minS
1944-10-01Respiratory rate14/minS
1944-10-01Body temperature36.6CelS
1944-10-01Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1944-10-01Mean score [PEG]7{score}S

Physical Exam

Vital signs recorded on 1944-10-01; see the Vital Signs section. [S]

SystemFinding
GeneralAlert and talkative; not sedated; pupils equal and normal in size
BackLumbar paraspinal tenderness; healed lumbar surgical scars
Right ankleBony enlargement and reduced motion; no effusion; foot turned outward
NeurologicalRight leg weakness and reduced reflexes, unchanged from intake
GaitWalks with a cane and a limp from the shorter right leg

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic low back and pelvic pain after remote spinal and pelvic fractures and spinal surgery, with neuropathic features in the right leg; linked to the documented 1843 injuriesactiveconfirmed G89.21S — Synthetic modern diagnosis linked to the documented injuries; the neuropathic interpretation is R.
Post-traumatic osteoarthritis of the right ankle and foot after multiple leg fractures and a foot dislocationactiveconfirmed M19.171S — Synthetic diagnosis confirmed on the synthetic ankle X-ray.
Right leg weakness, atrophy, and shortening after childhood poliomyelitis; a congenital spinal anomaly has been proposed retrospectivelyactiveprovisional B91S — Synthetic modern coding of the documented childhood diagnosis; the alternative remains R.
Long-term opioid therapy for chronic pain, 60 MME a day at intakeactiveconfirmed Z79.891S — Synthetic modern medication status; not a historical assertion.
Vitamin D deficiencyactiveconfirmed E55.9S — Synthetic finding from the baseline 25-hydroxyvitamin D.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPEG pain, enjoyment of life, and general activity scoreEvery visitCompleted today7.0, from 7.3 at intake
SurveyPHQ-9 depression score, with item 9Every 2 to 4 weeks during active treatmentUp to date8 at intake with item 9 scored 0; next at the four-week visit
Medication safetyOpioid benefits and harms: function, sedation, constipation, fallsEvery visit during a taper; at least every 3 monthsCompleted todayNo sedation, constipation, or falls; function slowly improving
Medication safetyPrescription drug monitoring program checkBefore each opioid prescription; at least every 3 monthsUp to dateChecked at intake: a single prescriber and no sedatives. No opioid prescription today
LaboratoryUrine drug test, with consentBefore long-term therapy, then at least annuallyUp to dateAt intake, consistent with the prescribed oxycodone only
Medication safetyNaloxone at home, with a family member trainedOffer when starting or continuing opioids; review each visitUp to dateDispensed at intake, with her spouse taught to use it
Medication safetyConcurrent benzodiazepines or other sedativesEvery visitCompleted todayNone prescribed or taken
Medication safetyDuloxetine tolerance after startingAbout 2 weeks after starting and after each dose changeCompleted todayBrief nausea only; blood pressure 116/72. Increased to 60 mg
LaboratoryALT on regular acetaminophenPeriodically when acetaminophen approaches 3 g a dayUp to date22 U/L at intake; recheck at the six-week review
LaboratoryCBC, creatinine, and blood pressure for chronic oral NSAID useEvery 6 to 12 months on oral NSAIDsNot indicatedTopical diclofenac only; creatinine 0.72 at intake
ExaminationRight ankle examination: range of motion, effusion, alignmentEvery visitCompleted todayBony enlargement and reduced motion; no effusion
ImagingRight ankle radiographOnly for diagnostic uncertainty, clinical change, or surgical planningNot indicatedDone at intake; no routine surveillance imaging
ReferralPhysical medicine and rehabilitationOnce, for a multimodal rehabilitation planCompleted todaySeen today; physical therapy and a shoe lift
ReferralCognitive behavioral therapy for chronic painEarly in a multimodal planReferredReferred today
Self-managementExercise program adherenceEvery visitCompleted todayPhysical therapy twice weekly starts today, with home exercises
Laboratory25-hydroxyvitamin DAbout 3 months after starting repletionDue18 ng/mL at intake; recheck in about eleven weeks

Goal progress:

Guideline basis: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); VA/DoD Clinical Practice Guideline for the Diagnosis and Treatment of Low Back Pain (2022); CMID: Clinical Monitoring Intelligence Database, osteoarthritis and depression monographs (2026)

Follow-up: Physical therapy twice weekly. Four-week chronic pain follow-up in two weeks for the first oxycodone reduction. Next scheduled visit 1944-10-15: four-week chronic pain follow-up with the first opioid dose reduction. [S]